acebutolol and ferlixit

acebutolol has been researched along with ferlixit in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's10 (83.33)24.3611
2020's2 (16.67)2.80

Authors

AuthorsStudies
Arneth, B; Bornstein, SR; Fischer, S; Julius, U; Schatz, U; Siegels, D; Siegert, G1
Biggar, P; Hahn, KM1
Münch, HG; Potthoff, SA1
Arneth, B; Bornstein, SR; Heigl, F; Hettich, R; Illigens, BM; Julius, U; Prophet, H; Ramlow, W; Schatz, U; Siegels, D; Siegert, G; Siepmann, T1
Connor, JR; Nixon, AM; Perno, JR; Webb, B; Zhang, X1
Marmifero, M; Meregaglia, M; Rognoni, C; Tarricone, R; Venturini, S1
Crumbliss, AL; Gupta, A; Pratt, RD1
Fell, LH; Fliser, D; Heine, GH; Rotter, B; Seiler-Mußler, S; Sellier, AB; Sester, M; Winter, P; Zawada, AM1
Coyne, DW; Daloul, R; Pandey, R1
Auerbach, M; Macdougall, I1
Caccamo, G; Di Franco, A; Giallauria, F; Nugara, C; Sarullo, FM; Sarullo, S; Vitale, G; Vitale, S1
Albanesi, M; Caiaffa, MF; Di Bona, D; Di Girolamo, A; Loconte, F; Macchia, L1

Reviews

5 review(s) available for acebutolol and ferlixit

ArticleYear
[Importance of the different i.v. iron generations for everyday medical practice].
    MMW Fortschritte der Medizin, 2013, Mar-21, Volume: 155 Suppl 1

    Topics: Anemia, Iron-Deficiency; Disaccharides; Dose-Response Relationship, Drug; Drug Substitution; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Humans; Infusions, Intravenous; Iron-Dextran Complex; Maltose; Structure-Activity Relationship; Treatment Outcome

2013
[Safety aspects of parenteral iron supplementation therapies in patients with chronic kidney disease].
    Deutsche medizinische Wochenschrift (1946), 2013, Volume: 138, Issue:24

    Topics: Administration, Oral; Anaphylaxis; Anemia, Iron-Deficiency; Disaccharides; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Humans; Infusions, Intravenous; Iron Compounds; Iron-Dextran Complex; Kidney Failure, Chronic; Maltose; Oxidative Stress; Renal Dialysis

2013
Efficacy and Safety of Ferric Carboxymaltose and Other Formulations in Iron-Deficient Patients: A Systematic Review and Network Meta-analysis of Randomised Controlled Trials.
    Clinical drug investigation, 2016, Volume: 36, Issue:3

    Topics: Administration, Intravenous; Chemistry, Pharmaceutical; Ferric Compounds; Hemoglobins; Humans; Iron Deficiencies; Maltose; Randomized Controlled Trials as Topic

2016
Iron Treatment Strategies in Dialysis-Dependent CKD.
    Seminars in nephrology, 2016, Volume: 36, Issue:2

    Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Disaccharides; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrosoferric Oxide; Glucaric Acid; Hematinics; Hemoglobins; Humans; Iron Compounds; Iron-Dextran Complex; Kidney Failure, Chronic; Maltose; Renal Dialysis; Transferrin

2016
The available intravenous iron formulations: History, efficacy, and toxicology.
    Hemodialysis international. International Symposium on Home Hemodialysis, 2017, Volume: 21 Suppl 1

    Topics: Anemia; Drug Compounding; Ferric Compounds; Ferrosoferric Oxide; Humans; Infusions, Intravenous; Iron; Kidney Failure, Chronic; Maltose; Renal Dialysis

2017

Trials

1 trial(s) available for acebutolol and ferlixit

ArticleYear
Iron deficiency and its management in patients undergoing lipoprotein apheresis. Comparison of two parenteral iron formulations.
    Atherosclerosis. Supplements, 2013, Volume: 14, Issue:1

    Topics: Aged; Anemia, Iron-Deficiency; Biomarkers; Blood Component Removal; Chemistry, Pharmaceutical; Drug Administration Schedule; Dyslipidemias; Female; Ferric Compounds; Ferritins; Germany; Hematinics; Humans; Infusions, Intravenous; Lipoproteins; Male; Maltose; Middle Aged; Time Factors; Transferrin; Treatment Outcome

2013

Other Studies

6 other study(ies) available for acebutolol and ferlixit

ArticleYear
TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients --A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltose.
    Atherosclerosis. Supplements, 2015, Volume: 18

    Topics: Aged; Anemia, Iron-Deficiency; Biomarkers; Blood Component Removal; Drug Administration Schedule; Female; Ferric Compounds; Ferritins; Germany; Hematinics; Humans; Hyperlipoproteinemias; Infusions, Intravenous; Iron; Lipoproteins, LDL; Male; Maltose; Middle Aged; Prospective Studies; Time Factors; Transferrin; Treatment Outcome

2015
Comparative evaluation of nephrotoxicity and management by macrophages of intravenous pharmaceutical iron formulations.
    PloS one, 2015, Volume: 10, Issue:5

    Topics: Animals; Cation Transport Proteins; Cell Line; Cell Survival; Disaccharides; Epithelial Cells; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrosoferric Oxide; Glucaric Acid; Hepcidins; Humans; Iron; Iron-Dextran Complex; Kidney; Lipid Peroxidation; Macrophages, Peritoneal; Maltose; Oxidative Stress; Primary Cell Culture; Rats; Tumor Necrosis Factor-alpha

2015
Ferrous iron content of intravenous iron formulations.
    Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2016, Volume: 29, Issue:3

    Topics: Administration, Intravenous; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Ferrous Compounds; Glucaric Acid; Iron-Dextran Complex; Maltose

2016
Impact of individual intravenous iron preparations on the differentiation of monocytes towards macrophages and dendritic cells.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2016, Volume: 31, Issue:11

    Topics: Anemia, Iron-Deficiency; Case-Control Studies; Cell Differentiation; Dendritic Cells; Disaccharides; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Iron Compounds; Macrophages; Maltose; MicroRNAs; Monocytes; Phagocytosis

2016
Effect of intravenous iron replacement therapy on exercise capacity in iron deficient anemic patients after cardiac surgery.
    Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2020, Mar-03, Volume: 90, Issue:1

    Topics: Aged; Anemia, Iron-Deficiency; Cardiac Surgical Procedures; Exercise Tolerance; Female; Ferric Compounds; Hematinics; Humans; Infusions, Intravenous; Male; Maltose; Middle Aged; Retrospective Studies; Treatment Outcome

2020
Desensitization in Iron Product Allergy.
    Acta haematologica, 2020, Volume: 143, Issue:5

    Topics: Adult; Anemia, Iron-Deficiency; Chlorpheniramine; Dexamethasone; Female; Ferric Compounds; Hematinics; Humans; Hypersensitivity; Iron; Maltose; Middle Aged; Skin Tests

2020